Glaxo announces deal with U.K. firm

GlaxoSmithKline PLC today announced an agreement with Biotica Technology Ltd., a privately held United Kingdom biotechnology company, to develop treatments for inflammatory diseases based on the antibiotic erythromycin.

Read More

Copyright PHILY - Philly.com
Contact Us